Uses rodent and non‑human primate disease models to study neurodegeneration and neuroinflammation. Integrates behavioral phenotyping, histology and functional/fluorescence imaging with neuropharmacology to map circuit plasticity and screen candidates for Parkinson’s and L‑DOPA–induced dyskinesia.